Imunon, Inc.
Key Metrics
Market Snapshot
About
Imunon, Inc. is a clinical-stage biopharmaceutical company focused on developing immunotherapies for cancer treatment. The company's pipeline includes targeted therapies designed to activate the immune system against tumor cells. Imunon utilizes multiple technology platforms including nucleic acid-based approaches and cell-based therapies. The company is advancing candidates through clinical trials for various cancer indications. Imunon aims to develop treatments that offer improved efficacy and safety profiles compared to existing standards of care.